Skip to content

Effect of Padmakadi Avaleha in Bronchitis

Prospective Single Arm Open Clinical Trial To Study The Efficacy Of Padmakadi Avaleha In Management Of Kaphaja Kasa With Special Reference To Bronchitis. - NIL

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077329
Enrollment
30
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40- Bronchitis, not specified as acuteor chronic

Interventions

None listed

Sponsors

Dr Supriya Maruti Ghorpade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients presenting with symptoms of Kaphaja kasa (Bronchitis) with kasa Vega (Bouts of cough),Kapha Nishthivan(Sputum Production),Shwaskrichata(Breathlessness),Urashool(Chest pain while coughing),Peenas(Common cold),Aruchi(Tasteless)as described in Ayurvedic Classics 2)Patients age between 18yrs to 70yrs of either sex 3)Patients without any bar of caste,religion, occupation, socioeconomic status

Exclusion criteria

Exclusion criteria: 1)Patients with known case of TB, Lung Cancer, Interstitial Lung Disease, Pneumonia, Pneumothorax 2)Patients with serious illness like HIV, Malignancy, Severe Cardiac Disease, Uncontrolled DM,Hepatic Disorder, Stroke, Arrhythmia or Evidence of Heart Failure and Auto Immune Disorder 3)Pregnant Women and Lactacting Mother

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Padmakadi Avaleha in Kaphaja Kasa.Timepoint: 7th day and 14th day

Secondary

MeasureTime frame
1.To evaluate any adverse effects of Padmakadi Avaleha in Kaphaja Kasa if any. Timepoint: 7th day and 14th day

Countries

India

Contacts

Public ContactDr Supriya Maruti Ghorpade

Sheth Chandanmal Mutha Aryangla Vaidyak Mahavidyalaya Satara

drpdlondhe4@gmail.com8830783292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026